Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes.

Ji-Qing ChenLucas A SalasJohn K WienckeDevin C KoestlerAnnette M MolinaroAngeline S AndrewJohn D SeigneMargaret R KaragasKarl T KelseyBrock C Christensen

Published in: Clinical epigenetics (2022)

Our results expand on the knowledge of immune profiles and methylation alteration associated with NMIBC outcomes and represent a first step toward the development of DNA methylation-based biomarkers of tumor recurrence.

Keyphrases

dna methylation
muscle invasive bladder cancer
genome wide
gene expression
healthcare
free survival
insulin resistance